HEALTH TIPS.: First ever HIV immunotherapy, involving ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals, proves safe in human phase 1 clinical trial, as reported in the journal Molecular Therapy.

Monday, 24 September 2018

First ever HIV immunotherapy, involving ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals, proves safe in human phase 1 clinical trial, as reported in the journal Molecular Therapy.

First ever HIV immunotherapy, involving ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals, proves safe in human phase 1 clinical trial, as reported in the journal Molecular Therapy.

submitted by /u/mvea
[link] [comments]

from Health https://ift.tt/2DqUPpJ
via IFTTT

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)